news roundup

Release of ADDPLAN neo Announced by ICON

ICON, a provider of drug development services, announced the release of ADDPLAN® neo, providing a technology platform for design, simulation, and analysis of adaptive clinical trials. The new release combines three modules, ADDPLAN® BASE, ADDPLAN® MC, and ADDPLAN® DF to become integrated under one robust framework.

BioIVT Acquires Clinical Trials Laboratory Services

BioIVT, a provider of research models and services for drug development, announced that it has acquired Clinical Trials Laboratory Services, a donor center and laboratory based in London, UK. With this acquirement, BioIVT hopes to ship high quality blood products and blood-derived immune cells efficiently to researchers throughout Europe.

New Whitepaper Outlines Patient Benefits of NHS High Throughput Centres

A new whitepaper has been released outlining the substantial benefits NHS High Throughput Centres could bring to UK patients, the NHS, and UK PLC. The set-up of High Throughput NHS Centres is potentially crucial in making the UK competitive after Brexit as it aspires to make the UK the country of choice for clinical research.

FDA Renews and Expands its Use of Certara Software

Certara, a provider of drug development, regulatory science, market access, and real-world evidence solutions, announced that the US Food and Drug Administration has renewed its number of Certara software licenses such as Certara Phoenix, Simcyp, and Synchrogenix GlobalSubmit, for reviewing new drug and biologics applications.

Articles

Patient Engagement Surveys in Clinical Trials: Dos, Don'ts, and How They Help

This article will address concerns and look at how the pragmatic implementation of surveys in today's clinical trials can provide valuable insight into patient satisfaction levels, motivators, likelihood to follow study requirements and information retention.

Human Centered Design–A Pathway to Patient Centricity

uMotif worked with IDEO to shape a patient-centric approach by focusing on human-centered design.

Ask the editor

Lisa Henderson
Editor in Chief
Lisa.Henderson@ubm.com